Phio Pharmaceuticals Corp (PHIO) — Cash Flow-to-Debt Ratio

Latest as of March 2026: -4.21x

Phio Pharmaceuticals Corp (PHIO) has a Cash Flow-to-Debt Ratio of -4.21x as of March 2026, meaning its operating cash flow of $-4.00 Million could theoretically repay -4% of its total liabilities ($950.00K) in one year. See financial flexibility index of Phio Pharmaceuticals Corp to measure the company's free cash flow as a share of total liabilities.

CF-to-Debt Ratio

-4.21x
Operating CF / Total Liabilities

Operating Cash Flow

$-4.00 Million
USD

Total Liabilities

$950.00K
USD

Data as of

Mar 2026
Most recent filing

Phio Pharmaceuticals Corp Cash Flow-to-Debt Ratio (2011–2025)

Historical debt coverage capacity for Phio Pharmaceuticals Corp across 15 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Phio Pharmaceuticals Corp.

Annual Cash Flow-to-Debt Ratio for Phio Pharmaceuticals Corp (2011–2025)

Year-by-year debt coverage analysis for Phio Pharmaceuticals Corp.

Year CF-to-Debt Ratio Operating CF (USD) Total Liabilities YoY Change
2025 -5.95x $-7.98 Million $1.34 Million ▲ +15.0%
2024 -7.01x $-7.11 Million $1.01 Million ▼ -6.5%
2023 -6.58x $-10.75 Million $1.63 Million ▼ -7.1%
2022 -6.14x $-12.13 Million $1.97 Million ▼ -67.8%
2021 -3.66x $-11.86 Million $3.24 Million ▼ -13.3%
2020 -3.23x $-8.80 Million $2.72 Million ▲ +14.3%
2019 -3.77x $-8.64 Million $2.29 Million ▲ +12.5%
2018 -4.31x $-7.52 Million $1.74 Million ▼ -2.7%
2017 -4.20x $-9.51 Million $2.27 Million ▼ -37.6%
2016 -3.05x $-7.76 Million $2.54 Million ▲ +5.3%
2015 -3.22x $-7.32 Million $2.27 Million ▼ -167.9%
2014 -1.20x $-7.76 Million $6.44 Million ▼ -90.7%
2013 -0.63x $-6.31 Million $10.00 Million ▼ -42.6%
2012 -0.44x $-5.06 Million $11.43 Million ▲ +89.9%
2011 -4.38x $-9.99 Million $2.28 Million
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.